No title
Antibodies have proven its usefulness in a variety of technologies, including Flow Cytometry, Immunohistochemistry and Antibody Microarrays. The latter, which has been applied in e.g. biomarker discovery, disease monitoring, prognostics and protein expression profiling, has become a workhorse in affinity proteomics. By recombinantly expressing scFv antibody fragments in E. coli, a high-throughput
